LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 2 of total 2

Search options

  1. Article: Associated effects of clinical characteristics, risk factors, and comorbidity on disease severity and mortality among patients with COVID-19 in Sulaimani City/ Kurdistan Region of Iraq.

    Aziz-Mawlood, Shakhawan / Ali, Salar Ibrahim / Babakir-Mina, Muhammed / Angeletti, Silvia / Dimonte, Salvatore / Pellegrino, Michele / Ciccozzi, Massimo / Aquaro, Stefano

    The new microbiologica

    2023  Volume 46, Issue 2, Page(s) 170–185

    Abstract: The effects of clinical symptoms, laboratory indicators, and comorbidity status of SARS-CoV-2-infected patients on the severity of disease and the risk of death were investigated. Questionnaires and electronic medical records of 371 hospitalized COVID-19 ...

    Abstract The effects of clinical symptoms, laboratory indicators, and comorbidity status of SARS-CoV-2-infected patients on the severity of disease and the risk of death were investigated. Questionnaires and electronic medical records of 371 hospitalized COVID-19 patients were used for data collection (demographics, clinical manifestation, comorbidities, laboratory data). Association among categorical variables was determined using Kolmogorov-Smirnov test (P-value ≤0.05). Median age of study population (249 males, 122 females) was 65 years. Roc curves analysis found that age ≥64 years and age ≥67 years are significant cut-offs identifying patients with more severe disease and mortality at 30 days. CRP values at cut-off ≥80.7 and ≥95.8 significantly identify patients with more severe disease and mortality. Patients with more severe disease and risk of death were significantly identified with platelet value at the cut-off ≤160,000, hemoglobin value at the cut-off ≤11.7, D-Dimer values ≥1383 and ≥1270, and with values of neutrophil granulocytes (≥8.2 and ≤2) and lymphocytes (≤2 and ≤2.4). Detailed clinical investigation suggests granulocytes together with lymphopenia may be a potential indicator for diagnosis. Older age, several comorbidities (cancer, cardiovascular diseases, hypertension) and more laboratory abnormalities (CRP, D-Dimer, platelets, hemoglobin) were associated with development of more severity and mortality among COVID-19 patients.
    MeSH term(s) Male ; Female ; Humans ; Aged ; Middle Aged ; COVID-19/epidemiology ; SARS-CoV-2 ; Iraq/epidemiology ; Retrospective Studies ; Comorbidity ; Risk Factors ; Patient Acuity
    Language English
    Publishing date 2023-05-01
    Publishing country Italy
    Document type Journal Article
    ZDB-ID 756168-4
    ISSN 1121-7138 ; 0391-5352
    ISSN 1121-7138 ; 0391-5352
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Health related factors contributing to COVID-19 fatality rates in various communities across the world.

    Shakor, Jamal Kareem / Isa, Rawand Abdulrahman / Babakir-Mina, Muhammed / Ali, Salar Ibrahim / Hama-Soor, Taib Ahmad / Abdulla, Jangy Esmail

    Journal of infection in developing countries

    2021  Volume 15, Issue 9, Page(s) 1263–1272

    Abstract: Introduction: Factors such as comorbidity, age and gender distribution are mostly related to hospitalization, numbers requiring intensive care and case fatality rate. In this review, the fatality rate of coronavirus disease 2019 (COVID-19) in different ... ...

    Abstract Introduction: Factors such as comorbidity, age and gender distribution are mostly related to hospitalization, numbers requiring intensive care and case fatality rate. In this review, the fatality rate of coronavirus disease 2019 (COVID-19) in different population health background according to comorbidity, age, gender distribution, and laboratory prognosis for COVID-19.
    Methodology: The current review was based on the data from copious studies that had homogeneity in relation to the review's objectives. It included the newest studies from December 2019 to September 2020. The epidemiological reasons for the high morbidity and mortality rates among COVID-19 patients were analyzed in different countries.
    Results: The highest comorbidity prevalence of COVID-19 was recorded in the United States of America (USA) (93.9%) and Italy (68%). Among population health background factors, comorbidity was the most common cause of COVID-19 fatality in the USA. The mean age of the most COVID-19 fatalities was more than 60 years old. Most of the studies show that 60% of COVID-19 patients were male. The fatality rates for the age group of 80-89 years-old in Korea, China, and Italy were 8.7 %, 14.7 %, and 18.8 % respectively. Lymphocytopenia has been observed in 91% of COVID-19 death cases. C - reactive protein had increased in 40-60% of COVID-19 patients.
    Conclusions: Many factors contribute to COVID-19 severity and fatality rates. Comorbidity, age, and gender were the main reasons for the Case Fatality Rate. This review recommends to follow preventive measures for overcoming the challenges faced during this emerging pandemic disease.
    MeSH term(s) Adult ; Age Factors ; Aged ; Aged, 80 and over ; C-Reactive Protein ; COVID-19/mortality ; China/epidemiology ; Comorbidity ; Female ; Humans ; Italy/epidemiology ; Lymphopenia ; Male ; Middle Aged ; Pandemics ; Republic of Korea/epidemiology ; Sex Factors ; United States/epidemiology
    Chemical Substances C-Reactive Protein (9007-41-4)
    Language English
    Publishing date 2021-09-30
    Publishing country Italy
    Document type Journal Article ; Review
    ZDB-ID 2394024-4
    ISSN 1972-2680 ; 2036-6590
    ISSN (online) 1972-2680
    ISSN 2036-6590
    DOI 10.3855/jidc.13876
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top